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Summary
Objective: The interactions between integrins and extracellular matrix proteins are known to modulate cell behavior, and may be involved in
regulating cartilage formation and repair. The purpose of this study was to determine the patterns and localization of expression of the 1
integrins during cartilage formation by periosteum, which is used to repair articular cartilage.
Design: Periosteal explants from 2-month-old rabbit medial proximal tibiae were cultured in agarose suspension for 0 to 6 weeks, with
10 ng/ml transforming growth factor-1 added for the Þrst 2 days of culture. Integrin expressions were measured by reverse transcriptase-
polymerase chain reaction (RT-PCR) and localized by immunohistochemistry.
Results: Normal periosteum expressed the 1, 3, 5, 1 subunits at low levels, and the proteins for all but the 3 subunits were identiÞed
by immunohistochemistry in the periosteum. SigniÞcant two- to Þve-fold up-regulation of the mRNA expression of the 1, 3, 5 and 1
integrin subunits during the early proliferative stage of chondrogenesis was observed. The initial change was a Þve-fold increase in 5
expression on day 2 and a two-fold increase in 3 expression. On day 5, 1 expression was up-regulated (four-fold). 1 expression was
broadly up-regulated (three to four-fold) from day 5 to 14. In the early stage of chondrocyte differentiation, after day 14, 1 expression was
down-regulated, while there was upregulation of 3 (three-fold), 5 (three-fold) and 1 (four-fold) expressions. Thereafter, 1 expression
was down-regulated, while 3, 5 and 1 expressions were up-regulated again during matrix synthesis. Immunohistochemistry conÞrmed
this late decrease in 1 levels and increase in 3, 5 and 1 levels in chondrocytes.
Conclusions: These observations indicate that the 1 integrins play an important role in the process of chondrogenesis in periosteum.
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Damaged articular cartilage has a limited potential for repair
with hyaline cartilage, and may progress to degenerative
arthritis1,2. Biological resurfacing of damaged articular car-
tilage with autologous periosteal transplantation has been
shown to be possible in experimental models37 and has
been used in clinical studies810. Periosteum contains
undifferentiated mesenchymal stem cells in the cambium
layer, which can undergo both chondrogenesis and
osteogenesis1113. Mechanisms involved in periosteal
chondrogenesis during articular cartilage regeneration
include complex interactions among mesenchymal cells,
chondrocytes, extracellular matrix (ECM) and growth
factors. However, the molecular and cellular events in this
chondrogenesis are practically unknown. To investigate the
regulation of periosteal chondrogenesis, and the process
itself as it relates to cartilage repair, an organ culture system
in agarose suspension has been established1417.135Cartilaginous differentiation from mesenchymal tissues
is characterized by speciÞc changes in the ECM com-
ponents present in these tissues1822. The ECM com-
ponents relevant to chondrogenesis include collagens,
proteoglycans, hyaluronic acid, elastin, Þbronectin and
laminin. SpeciÞc changes in ECM proteins occur during
chondrogenesis in limb development. The ECM modulates
cell physiology by directing the cells to adhere, migrate,
proliferate, differentiate and synthesize matrix2326. This is
achieved by the interactions between the ECM and cell
surface receptors, mainly the integrin family. Integrins are
heterodimeric transmembrane glycoproteins composed of
one  and one  subunit, which determine both ligand and
signaling speciÞcity.
Normal articular chondrocytes have been reported to
express several different integrins including 11, 31,
51, v3 and v52729. Among them, 1 integrins are
thought to predominantly mediate the interactions between
chondrocytes and ECM proteins3032. 11 serves as a
receptor for collagens and laminin33,34, 51 for Þbro-
nectin35 and 31 for collagens, Þbronectin and laminin36.
In a paucicellular and avascular tissue such as articular
cartilage, cell-ECM interactions are critical in regulating
chondrocyte metabolism. It is likely that integrins play an
important role during periosteal chondrogenesis by inter-
acting with components of ECM. In this study, we investi-
gated the expression and localization of the 1 integrins
using an in vitro organ culture system to determine the
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CULTURE OF PERIOSTEAL EXPLANTS
A total of 160 periosteal explants, measuring 2×3 mm,
were harvested by sharp subperiosteal dissection4 from the
medial sides of both proximal tibiae of 20 two-month old
male New Zealand White rabbits weighing an average of
1.75 kg. All periosteal explants were obtained within 30 min
after death to control for postmortem effects on chondro-
genic potential14. One hundred and twenty explants
were used for reverse transcriptase polymerase chain
reaction (RT-PCR) and 40 explants were used for
immunohistochemistry.
The explants were cultured in agarose suspension
using a previously described method14. Immediately after
surgical harvesting, the periosteal explants were placed
in Dulbeccos ModiÞed Eagle Medium (DMEM) (Life
Technologies, Grand Island, NY), with penicillin/
streptomycin (50 U/ml and 50 g/ml) (Life Technologies)
and 1 mM proline (Sigma Chemical Co., St. Louis, MO) at
4°C for no more than 1.5 h prior to placement into the
culture wells. Twenty-four-well ßat bottom culture plates
(Corning Glass Works, Corning, NY) were pre-coated with
high Tm agarose gel (Bio-Rad Laboratories, Richmond,
CA). The explants were suspended in 1 ml of a 1:1 mixture
of 1.0% low Tm agarose gel (Bio-Rad Laboratories) and 2×
concentration of DMEM. The Þnal suspension agarose gel
contained 0.5% low Tm agarose gel, 1× DMEM, 1 mM
proline, penicillin/streptomycin (50 U/ml and 50 g/ml) and
10 ng/ml porcine transforming growth factor-1 (TGF-1)
(R & D Systems, Minneapolis, MN). The agarose gel was
allowed to fully congeal at 4°C for 5 min. Each 1.0 ml of gel
layer was covered with 1.0 ml of DMEM containing 10%
fetal calf serum (Life Technologies), 1 mM proline,
penicillin/streptomycin (50 U/ml and 50 g/ml), 50 g/ml
ascorbic acid and 10 ng/ml TGF-1. The medium above the
gel layer was replaced every second day. Ten ng/ml
TGF-1 was used for the Þrst 2 days14,15. Ascorbic acid
was added daily for a Þnal concentration of 25 g/ml.
Cultures were maintained at 37°C and 5% CO2/95% air for
0, 2, 5, 7, 10, 14, 21, 28, 35 or 42 days.TOTAL RNA EXTRACTION AND CDNA SYNTHESIS
Total RNA was extracted from 12 periosteal explants
from different rabbit donors at each time point using Trizol
reagent (GIBCO BRL, Grand Island, NY), as described
previously16. Two g of RNA were treated with 0.2 U/l
DNase I (GIBCO BRL) to remove the contaminating
genomic DNA followed by inactivation of the enzyme
with EDTA. This was then converted to cDNA using 10 U/l
superscript II reverse transcriptase (GIBCO BRL) and ran-
dom primers (Roche Molecular Biochemicals, Mannheim,
Germany).POLYMERASE CHAIN REACTION (PCR)
PCR was carried out in a 20 l of reaction mixture
containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM
MgCl2, 100 M each of four deoxyribonucleoside tri-
phosphate (Roche Molecular Biochemicals), 2 pmol each
primer, 1 l of cDNA and 0.5 U of AmpliTaq DNA poly-
merase (Perkin Elmer, Norwalk, CT). AmpliÞcation was
performed for 3035 cycles with denaturation at 94°C for
1 min, annealing at 5065°C for 2 min and elongation at
72°C for 3 min.Table I
Oligonucleotide primers used for PCR to isolate partial cDNA sequences of rabbit 1, 3, 5 and 1 integrin
subunits*
cDNA Primer Sequences (5′→3′) Location in
cDNA
Size of
PCR
1 subunit 5′ CAGTTTAACACATCC(T/C)ATCTC(A/T)(T/C)GG 27222746 327
3′ ATGACCATCTGATGTCAGGTTGGGG 30483024
3 subunit 5′ GGTTCTCTGTGGACATTGACTC 29913012 240
3′ CTCAGTAGTCGTCGGTCAGC 32303211
5 subunit 5′ CATTTCCGAGTCTGGGCCAAGA 28322853 339
3′ GGCATCAGAGGTGGCTGGAG 31703151
1 subunit 5′ CAGTGAATGGGAACAACGAGG 22202240 277
3′ TTTCCCTCATACTTCGGATTGACC 24962473
*The primer sequences correspond to the nucleotide positions of the human integrin 1 (34), 3 (36), 5 (35)
and 1 (35) subunits.ISOLATION OF PARTIAL CDNA SEQUENCES OF RABBIT 1, 3, 5
AND 1 INTEGRIN SUBUNITS
Partial cDNA sequences were isolated using the method
of gene digging, as previously described37. In this method,
rabbit growth plate cDNA was used as a template for PCR.
For the isolation of cDNA sequences for rabbit 1, 3, 5
and 1 integrin subunits, the primers were designed based
on the conserved nucleotide sequences between
human3436 and rat (1 and 1)33,38 or mouse (3 and 5),
and based on the partially known rabbit sequences (5 and
1)39. The nucleotide sequences of these primers are
shown in Table I. PCR was performed for 35 cycles with
denaturation at 94°C for 1 min, annealing at 50°C for 2 min
and elongation at 72°C for 3 min. PCR products were
electrophoresed on agarose gel and the each band was
sequenced by direct automated sequencing using the
same primers that had been used for PCR.timing of any potential involvement of cell-ECM interactions
during periosteal chondrogenesis.
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Quantitation of integrin subunit mRNA levels was per-
formed by competitive quantitative PCR that involved sim-
ultaneous coampliÞcation of both the target mRNA and an
exogenously added homologous template with the same
set of primers40. For this purpose, we constructed a
homologous internal standard by PCR, which was shorter
than each target fragment, but with identical 5′ and 3′ end
sequences. The nucleotide sequences of these primers are
shown in Table II. As a result, one set of the primers
simultaneously ampliÞed both the target segment and the
internal standard with the same efficiency of annealing,
although differences in size, base composition and poten-
tial secondary structure could result in differences in ampli-
Þcation efficiency. The appropriate concentration of internal
standard and PCR parameters were determined for optimal
coampliÞcation of both fragments (data not shown). An
identical amount of the internal standard for each integrin
subunit was added to each PCR reaction mix. AmpliÞcation
was carried out for 30 cycles with denaturation at 94°C for
1 min, annealing at 60°C (1, 3 and 1) or 65°C (5) for
2 min, and elongation at 72°C for 3 min in the presence of
2 Ci of 32P dCTP (Dupont-NEN, Boston, MA). The PCR
products were electrophoresed on agarose gels, which
were then dried under vacuum, and the radioactive bands
were quantitated using a phosphorimager (Molecular
Dynamics, Sunnyvale, CA). The intensity of each band was
normalized to that of 10 pM of each internal standard.IMMUNOHISTOCHEMISTRY
To detect and localize the cells expressing integrins
during periosteal chondrogenesis, immunohistochemistry
for each integrin subunit was performed. The explants from
each time point were Þxed in 4% paraformaldehyde/sodium
phosphate buffer (pH 7.4) for 4 h at 4°C, and embedded in
paraffin. Serial histological sections, 4 m in thickness,
were cut perpendicular to the original cambium surface of
the periosteum from the middle, and stained with safranin
O/fast green to observe the cambium layer, cartilage and
Þbrous layer in periosteum. The sections were deparaffin-
ized with xylene and hydrated with serial concentrations of
60, 80, 95, and 100% ethanol. Endogenous peroxidase
activity was blocked with 0.6% hydrogen peroxide in
methanol for 1 h. Following three washes in tris-bufferedsaline (TBS)/0.1% BSA, nonspeciÞc binding of antibody
was blocked with 1.5% normal rabbit (1, 3 and 5) or
horse (1) serum (Vector Laboratories, Burlingame, CA) in
TBS/0.5% BSA for 15 min at room temperature. The
sections were then incubated with goat polyclonal anti-
bodies against integrin 1, 3 or 5 subunits with a 1:800
dilution, or mouse monoclonal antibodies against 1 sub-
unit (Santa Cruz Biotechnology, Santa Cruz, CA) with a
1:25 dilution overnight at room temperature in a humidiÞed
chamber. After three washes in TBS/0.1% BSA, sections
were incubated with biotinylated rabbit antigoat IgG (1,
3 and 5) or horse anti-mouse IgG (1) (Vector
Laboratories) for 1 h at room temperature. Following three
washes in TBS/0.1% BSA, avidin-biotin complex (Vector
Laboratories) was applied for 30 min at room temperature.
After extensive washes, the sections were reacted with
diaminobenzidine (DAB) (Sigma) for 2 min, then dehy-
drated and mounted. Goat (1, 3 and 5) or mouse (1)
IgG (Santa Cruz Biotechnology) was used as a control
primary antibody.QUANTIFICATION FOR IMMUNOHISTOCHEMISTRY
The number of cells expressing integrin subunits
was assessed by cell counting using the Vidas 2.1 Image
Analysis system with a Zeiss Axioskop microscope.
Cambium, cartilage and Þbrous areas in the periosteal
explants were identiÞed in sections stained with safranin
O/fast green. Only cells within the cambium and cartilage
area were included. The total number of cells and the
number of positively stained cells were counted in three
randomly selected Þelds per section from three to four
different explants at ×200 magniÞcation. The staining ratio
for each Þeld was calculated dividing the number of positive
stained cells by the total number of cells. The staining ratio
was evaluated as: (no staining), ±: (<5%), +: (525%), ++:
(2550%), +++: (5075%), and ++++: (>75%).Table II
Oligonucleotide primers used for competitive quantitative PCR for 1, 3, 5 and 1 integrin subunits*
cDNA Primer Sequences (5′→3′) Location in
cDNA
Size of
PCR
1 subunit 5′ CAGTGAAGAACCTCCTGAAGCCC 27812803 268
Internal 5′ primer+ATTGCGGCCAATGAGACAGTCCC 28932915 179
3′ Same as 1 3′ primer in Table 1.
3 subunit 5′ CGAGATCGAGCTGTGGCTGGT 30373057 171
Internal 5′ primer+CATCCTGTTACTGTGGAAGTGC 31003121 129
3′ TCCGTCTCTGACGGCTGGCTCTT 32073185
5 subunit 5′ AGTGCGAGGCTGTGTACAA 28902908 266
Internal 5′ primer+CCACTGTGATCATCATCCTAGCCA 30153039 160
3′ TGGAGGCTTGAGCTGAGCTTTTTCC 31553131
1 subunit 5′ AGACTCCAGAGTGCCCCACTGGT 22592281 235
Internal 5′ primer+CCTTGCACTGCTGCTGATTTG 23332355 184
3′ CCCTCATACTTCGGATTGACCAC 24932471
*The primer sequences correspond to the nucleotide positions of the human integrin 1 (34), 3 (36), 5 (35)
and 1 (35) subunits.STATISTICAL ANALYSES
Statistical analyses were performed using 1 factor
ANOVA with Duncans New Multiple Range post-hoc test-
ing or 2-factor ANOVAwith mean-based contrast testing. All
data are expressed as mean±standard error.
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Clinic Institutional Animal Care and Use Committee.ResultsISOLATION OF PARTIAL CDNA SEQUENCES OF RABBIT 1, 3, 5
AND 1 INTEGRIN SUBUNITS
We Þrst isolated partial cDNA sequences of rabbit 1, 3,
5 and 1 integrin subunits by the method of gene dig-
ging37, since rabbit-speciÞc cDNA sequences are needed
for PCR, and only the 1 and 3 subunits were partially
known39. Using rabbit growth plate cDNA as a template
and the primers based on conserved nucleotide sequences
across the known species, we ampliÞed a 327 bp fragment
for the 1 subunit, a 240 bp fragment for the 3 subunit, a
339 bp fragment for the 5 subunit, and a 277 bp fragment
for the 1 subunit by PCR (Table I). The 327 bp fragment
showed 92% and 86% homology to human and rat 1
subunit, respectively. The 240 bp fragment showed 95%
and 91% homology to human and mouse 3 subunit,
respectively. The 339 bp fragment showed 88% and 85%
homology to human and mouse 5 subunit, respectively.
The 277 bp fragment showed 93% and 92% homology to
human and rat 1 subunit, respectively. These resultsindicate that these fragments are homologues of the 1, 3,
5 and 1 integrin subunits.Fig. 1. Autoradiographic results for the analysis of RT-PCR products. Periosteal explants were cultured in agarose with 10 ng/ml TGF-1 for
the Þrst 2 days for 0 to 6 weeks. Total RNA from each time point was extracted and reverse-transcribed to cDNA. Competitive quantitative
PCR for 1, 3, 5 and 1 integrin subunits was performed by simultaneous coampliÞcation of both the target fragment and an exogenously
added homologous internal standard (Int. Std.) in the presence of 32P dCTP with rabbit-speciÞc primers.EXPRESSION PATTERNS OF 1, 3, 5 AND 1 INTEGRIN SUBUNIT
MRNAS
Based on the isolated sequences for rabbit 1, 3, 5
and 1 subunits, we designed the speciÞc primers to
generate homologous internal standards and to perform
competitive quantitative PCR (Table II). These primers
speciÞcally ampliÞed the corresponding sequences as
determined by direct sequencing of the ampliÞed products
(data not shown). Then, we examined the expression
patterns of the 1, 3, 5 and 1 subunits during periosteal
chondrogenesis. In this periosteal explant culture system,
neochondrocytes appeared on day 14, then increased in
prevalence up to 6 weeks (see Figs 3 and 4). RT-PCR
detected mRNA expressions of all these subunits in day 0
periosteum immediately after harvest, and at varying levels
during the whole culture period of periosteal chondro-
genesis (Fig. 1). The expressions of these subunit mRNAs
were quantitated and normalized to 10 pM of each internal
standard (Fig. 2). The 1 subunit had a sharp monophasic
expression pattern, which was markedly up-regulated on
day 5 (four-fold) (P<0.05), then immediately decreased to
Osteoarthritis and Cartilage Vol. 10, No. 2 139the basal (day 0) level on day 7, and was downregulated to
lower than the basal level (P<0.05) after day 14 [Fig. 2(a)].
The 3 subunit had a biphasic expression pattern, that Þrst
peaked on day 2 (two-fold) (P<0.05), decreased to the
basal level on day 5, then peaked again on day 35
(three-fold) (P<0.05) [Fig. 2(b)]. The 5 subunit was
up-regulated on day 2 (Þve-fold) (P<0.05) and 10 (four-fold)
(P<0.05), then decreased to the basal level on day 14, and
peaked again on day 35 (three-fold) (P<0.05) [Fig. 2(c)].
The 1 expression showed sustained (three to four-fold)
up-regulation from day 5 to 14 (P<0.05), gradually
decreased to the basal level by day 21, then peaked again
on day 35 (four-fold) (P<0.05) [Fig. 2(d)].0
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Fig. 2. Quantitation of 1 (a), 3 (b), 5 (c) and 1 (d) integrin subunit mRNAs during periosteal chondrogenesis. Competitive quantitative
PCR was performed by simultaneous coampliÞcation of both the target fragment and an exogenously added homologous internal standard
(Int. Std.) in the presence of 32P dCTP with rabbit-speciÞc primers and parameters as described in the methods section. The PCR products
were electrophoresed on agarose gel, and the radioactive bands were quantitated using a phosphorimager. The intensity of each band was
normalized to that of 10 pM each internal standard. Groups with a letter in common are not statistically different from one another. Data are
expressed as mean±standard error (N=6).Table III
Immunohistochemistry for 1, 3, 5 and 1 integrin subunits during periosteal chondrogenesis*
0 d 2 d 5 d 7 d 10 d 14 d 21 d 28 d 35 d 42 d
1 subunit + ++ +++ +++ +++ +++ +++ ++ ++ ++ ++
3 subunit − ± ± ± ++ +++ +++ ++ ++ ++
5 subunit + ++ ++ ++ +++ +++ +++ +++ +++ +++
1 subunit + + ++ ++ ++ +++ +++ +++ +++ +++ +++
*The positive ratio of integrin subunit expressions was calculated by dividing the number of positive stained
cells by the total number of cells in the cambium layer, and was evaluated as: −: no staining; ±: <5%; +: 525%;
++: 2550%; +++: 5075%; ++++: >75%.IMMUNOHISTOCHEMICAL LOCALIZATION OF 1, 3, 5 AND 1
INTEGRIN SUBUNITS
The immunohistochemical expression patterns of the 1,
3, 5 and 1 integrin subunits during the time course of
periosteal chondrogenesis is summarized in Table III and
Figs 3 and 4. The 1 subunit was detected in more than
50% of the cambium layer cells and chondrocytes from
day 0 to 14. The percentage of 1-positive chondrocytes
gradually decreased after day 14 (Figs 3 and 4). The 3
subunit was not detected in the cambium layer on day 0,
and weakly detected in fewer than 5% cambium cells from
day 2 to day 7. After day 10, the expression of the 3
140 T. Fukumoto et al.: Integrins in periosteal chondrogenesissubunit gradually increased, until it was detected in more
than 50% of the chondrocytes from days 14 to 21, then
decreased to 25 to 50% of the cells from day 21 to day 42
(Figs 3 and 4). The 5 subunit was initially weakly detected
in fewer than 25% of the cambium cells, and then increased
on day 2 to 2550% of the cells. By day 10, and for the rest
of the 42 day culture period, the 5 subunit was detectable
in more than 50% of the cambium cells and chondro-
cytes (Figs 3 and 4). The 1 subunit was detected in
2550% cambium cells on day 0, and then had an identical
expression pattern as the 5 subunit (Figs 3 and 4).0 42
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Fig. 3. Schematic representation of the data summarized in Table
III showing the percentage of positively immunostained cells using
antibodies against the 1 ( ) 1, (  ), 5 (- - -) or 3
() integrin subunits. Immunoreactivity of the 1 was detected
initially in the cambium layer of the periosteum, and then it
progressively increased in the developing chondrocytes during the
culture. The 1 subunit couples with one of several a subunits
including 1, 3 and 5. Therefore, it is likely that the expression
pattern of the 1 integrin subunit may reßect the total expression
pattern of these a subunits.Discussion
Several general interpretations can be derived from the
data presented in this study. First, expression of the
mRNAs for the 1, 3, 5 and 1 integrin subunits are all
detectable in normal periosteum. Three of these subunits
(1, 5, and 1) were able to be identiÞed in the cambium
layer by immunohistochemistry. Second, their expression
patterns and the percentage of cells expressing them
changed dramatically during periosteal chondrogenesis.
Third, the changes in mRNA levels and the proportion of
cells expressing them were different for each integrin
subunit, but each change coincided with known stages
and expression of other cartilage-speciÞc genes during
periosteal chondrogenesis.
This in vitro organ culture system directs the undiffer-
entiated mesenchymal stem cells in the cambium layer of
the periosteum into the chondrogenic lineage14. The devel-
opment and maturation of neochondrocytes follow a
speciÞc time course involving at least four stages: commit-
ment, proliferation, differentiation, matrix synthesis and
organization41. Each stage is independently regulated by
growth factors and mechanical stimuli and separated by
transition-restriction points as in the Lian-Stein model of
osteoblast development42.The 5 1 integrin has been shown to regulate mech-
anotransduction in normal and osteoarthritic chondro-
cytes43. Although all four 1-integrin subunits (1, 3, 5,
1) were up-regulated in the Þrst 2 to 10 days, the 5
subunit was the only one to show a signiÞcant change in
the percentage of cells staining for it by immunohistochem-
istry in the Þrst 10 days. On day 0, 5 to 25% of the cells in
the cambium layer, where the chondrocyte precursors
reside, stained positively. This percentage increased to 25
to 50% of the cells on day 2. This correlates with the rapid
rise in expression of BMP2 and its receptors that we have
documented to occur in the Þrst 48 hours in this sys-
tem16,37. It also just precedes the dramatic rise in expres-
sion of TGF-1 (Mizuta H, Sanyal A, Fukumoto T, et al. The
spatiotemporal expression of TGF-1 and its receptors
during periosteal chondrogenesis in vitro. Accepted for
publication, J Orthop Res). Also, these periosteal explants
have been shown to respond to mechanical stimulation
within 24 hours44. This timing effect points to a potential
role of 51 integrins in the early regulation of periosteal
chondrogenesis.
In the proliferative stage, from days 2 to 10, mRNA
expressions of all these integrins were temporarily
up-regulated and their immunoreactivities were detected in
the cambium layer. After day 14, when neochondrocytes
were observed in the cambium layer, the 1 subunit was
down-regulated, whereas the 3, 5 and 1 subunits
showed peaks of up-regulation again on day 35 when the
cartilage extracellular matrix reaches a peak and plateaus.
These results reveal that the integrins are differentially
regulated to interact with speciÞc ECM proteins at various
stages of chondrogenesis. This suggests that they may
play potentially important roles in the initial induction of
periosteal chondrogenesis and again during organization of
the extracellular matrix.
The 5 expression was markedly up-regulated on days 2
and 10, and it was shown immunohistochemically to be
localized to the cambium layer. The only known ligand for
integrin 51 is Þbronectin31,32,35, which is expressed
during the condensation stage of chondrogenesis, suggest-
ing that it mediates initial cell-cell interactions21,22. We
have also observed the expression of Þbronectin mRNA
during this early stage of periosteal chondrogenesis
(data not shown). These observations, taken in light of
published work by others, can be interpreted to suggest
that 51 may contribute to the initial cell-cell interactions
among mesenchymal cells and/or prechondrocytes in the
cambium layer of the periosteum prior to subsequent
chondrogenic differentiation. We have already shown that
cell proliferation precedes chondrogenic differentiation45
and occurs during the Þrst 3 to 5 days of periosteal
chondrogenesis. Normal chondrocytes require mechanical
stimuli to maintain their extracellular matrix. The 51
subunit has been shown to be involved in mechanical
signal transduction in chondrocytes43. In our system, the
periosteal explants demonstrate a dramatic rise in 51
expression during the phase of extracellular matrix produc-
tion (aggrecan type II collagen)41 that correlates with a
signiÞcant enhancement by mechanical stimulation46. The
rise in both the 5 and 1 subunit presence by immuno-
staining on days 10 to 14 correlates with the dramatic rise
in collagen type II expression in early cartilage formation,
as demonstrated by PCR, in situ hybridization and immuno-
staining47. The sustained increase in 51 expression until
day 35 is consistent with the progressive accumulation
of collagen type II that peaks in cartilage matrix in the
periosteal explants between days 28 and 4241.
Osteoarthritis and Cartilage Vol. 10, No. 2 141Fig. 4. Safranin O/fast green staining (SO) and immunohistochemistry for 1, 1, 5 and 3 integrin subunits at different time points during
periosteal chondrogenesis: column 1day 0, column 2day 5, column 3day 14, and column 4day 35. Periosteal explants were cultured
in agarose with 10 ng/ml TGF-1 for the Þrst 2 days (magniÞcation=×200).
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Þbronectin and laminin36. However, Du¨rr et al. reported that
anti-3 subunit antibodies could not inhibit the attachment
of fetal chondrocytes to type I, II collagen and Þbronectin31.
Therefore, the possible ligands for integrin 31 in
chondrogenic cells might be other collagens or laminin.
Tavella et al. reported that 31 and laminin were
expressed maximally in aggregated cells, and then
decreased during chondrogenic differentiation in culture of
embryonic tibia22. The 3 submit expression was
up-regulated on day 2, decreased to the basal levels on
day 5, then increased again later during matrix organiz-
ation. Immunoreactivity of 3 was not detected on day 0,
but weakly observed in a small number of cambium cells
during the early stage of differentiation. It is possible that
31 might interact with laminin in the initial process of
chondrogenesis in periosteum.
The 1 expression was markedly up-regulated very
brießy immediately following the proliferative stage, during
the early phase of neochondrocyte differentiation. The 1
subunit was detected immunohistochemically in more
than 50% of the cambium cells throughout the commit-
ment, proliferation and early differentiation stages from
days 0 to 14, then diminished in the next 4 weeks.
Integrin 11 is reported to mediate the interactions
between chondrocytes and types I and II collagen31,32.
We have observed the expression of type I collagen
mRNA in the cambium layer in the Þrst 2 weeks (data not
shown). Type II collagen mRNA is detected in the cam-
bium layer as early as day 7, although it increases
dramatically between day 14 to 2147. These patterns are
similar to the switch in expression from type I to type II
collagen early during chondrogenesis in the embryo1820.
Shakibaei et al. reported similar co-expression patterns of
the 1 subunit and type I collagen during chondro-
genesis48. These lines of evidence suggest that the 1
subunit mRNA may be up-regulated to interact with colla-
gen during the early stage of periosteal chondrogenesis,
as it paralleled the expression pattern of type II collagen.
During the latter stages of chondrogenic differentiation,
after day 14, mRNA expressions and the immunoreactivi-
ties of 3 and 5 increased again, whereas those of 1
decreased. Ustoa Ma et al. reported that the 5 subunit
was strongly expressed in proliferating and hypertrophic
chondrocytes while 3 was detected in the prehyper-
trophic and hypertrophic chondrocytes during the devel-
opment of fetal articular cartilage49. Shakibaei et al.
documented a transition from expression of 1 to 3
subunit during chondrogenesis in culture of mesenchymal
cells from limb buds48. Taken together, 31 and 51
may be involved in not only the initial stage of chondro-
genesis but also in the later differentiation process of
chondrocytes.
It is possible that TGF-1 modulates the expression
patterns of 1 integrins. TGF- is known to stimulate
mesenchymal stem cells into chondrogenic differ-
entiation5052. In our periosteum organ culture system,
chondrogenesis is markedly enhanced and the time course
shortened by exogenous administration of TGF-1 for the
Þrst 2 days of culture14,15. Recently, Loeser reported that
TGF- increased 3 and 5 subunit expression but
decreased 1 in cultured articular chondrocytes, whereas
insulin-like growth factor 1 (IGF-1) increased all53. Although
the effects of TGF- vary depending on the type of cells and
cellular environment54,55, it is possible that the expres-
sion patterns of some or all of these integrins might be
modulated by the effect of TGF-.The 1 subunit was up-regulated broadly from day 5 to
14 and again later around day 35. Immunoreactivity of
the 1 was detected initially in the cambium layer of the
periosteum, and then it progressively increased in the
developing chondrocytes during the culture. The 1 subunit
couples with one of several a subunits including 1, 3 and
5. Therefore, it is likely that the expression pattern of the
1 integrin subunit may reßect the total expression pattern
of these  subunits.
In normal articular cartilage, 51 is the most prominent
integrin in chondrocytes, 11 is also substantial, but 31
expression is weak and variable2729. The relative mRNA
expressions and immunoreactivities among  subunits dur-
ing the later stage of periosteal chondrogenesis in this
study mimics the expression patterns in normal articular
cartilage in the previous reports.
In summary, we have demonstrated that the expression
patterns and immunolocalization of the 1, 3, 5 and 1
integrin subunits differ from each other in normal perio-
steum and during each stage of periosteal chondrogenesis.
The initial stage, during which mesenchymal stem cells are
committed to become chondrocyte precursors, is marked
by an immediate upregulation and accumulation of the 5
subunit. During the next stage, proliferation of chondrocyte
precursors, all subunits are up-regulated brießy. Early
chondrocytic differentiation is marked by down regulation of
the expression of all subunits as they have accumulated
and are detectable in the majority of the cells by immuno-
reactivity. The Þnal stage, during which chondrocytes
mature and organize the extracellular matrix, is heralded by
a dramatic rise in the expression of the 3, 5 and 1
subunits, while the 1 subunit expression remains low.
These results suggest that the  and 1 integrins play
important roles throughout the process of chondrogenic
differentiation in periosteum from undifferentiated mesen-
chymal cells through extracellular matrix deposition. The
timing of expression of the 51 integrin correlates closely
with the expression of other cartilage-speciÞc genes in this
system, as well as with the response of periosteal explants
to mechanical stimulation. Blocking their functions or
stimulating their expressions may further elucidate their
speciÞc cell-ECM interactions and roles in regulating perio-
steal chondrogenesis. An understanding of these events
and regulatory processes will be important for under-
standing fracture healing as well as cartilage repair and
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